Evidence map›Paper›PMID 42426864›Full record

ArticleBMC chemistry2026

Novel eco-friendly spectrophotometric determination of potential combination silodosin and darifenacin hydrobromide in bulk and pharmaceutical formulations.

Islam M Darwish, Omar M El-Abassy, Hanaa Saleh, Eman A Bahgat

Abstract read
In one paragraph

Article in BMC chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Islam M DarwishEgyptian Drug Authority, Giza, 12622, Egypt. islammohsen422@gmail.com.
Omar M El-AbassyPharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian Russian University, Badr City, 11829, Cairo, Egypt.
Hanaa SalehPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Eman A BahgatPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silodosin and darifenacin hydrobromide have lately been administered to males with overactive bladder for the management of benign prostatic hyperplasia. The present work details the development and validation of spectrophotometric methods that demonstrate reliability, accuracy, and selectivity for quantifying two medications in bulk and pharmaceutical formulations. Both drugs are quantified from the recorded spectra using different mathematical manipulations. Direct measurement of silodosin concentration was performed at a wavelength of 328.8 nm. The methods for determining darifenacin include Method I, which employs fourier self-deconvolution; Method II, which utilizes ratio difference analysis; and Method III, which applies first derivative ratio. The procedure parameters were validated following ICH recommendations. The methodologies included the direct quantification of silodosin within the range of 10-45 µg/mL with LOD and LOQ of 0.942 and 2.857 µg/mL respectively, as well as Fourier self-deconvolution, ratio difference, and first derivative ratio spectrophotometric techniques for the assessment of darifenacin hydrobromide within the range of 5-70 µg/mL with LOD and LOQ for each method of (0.484, 1.468 µg/mL), (1.353, 4.100 µg/mL), (0.794, 2.408 µg/mL), respectively. Recovery studies validated the accuracy of the methods in pharmaceutical formulations, with an average recovery of 100.37% for silodosin (direct method) and 100.96%, 99.87%, and 100.69% for darifenacin hydrobromide using fourier self-deconvolution, Ratio difference, and first derivative ratio methods, respectively. The procedures demonstrate a high level of environmental sustainability, as evidenced by Analytical GREEnness calculator (a comprehensive, flexible, and straightforward assessment approach that provides an easily interpretable and informative result for evaluating greenness), Modified Green Analytical Procedure Index (which merges the advantages of the visual impact of Green Analytical Procedure Index with the precise total score of the analytical Eco-Scale and provides an overall assessment of the method greenness by calculating a total score), spider chart, green solvents selection tool (spider chart and green solvent selection tools were applied to select and evaluate solvents used during the experiment) and Blue applicability grade index (evaluating the practicality of an analytical techniques).

Indexed as

DarifenacinFourier self-deconvolutionRatio derivativeRatio differenceSilodosinSpectrophotometric methods

Identifiers

PMID42426864
PMCPMC13352872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.